Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2013-12-05 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GRAVELINES (59820), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU CENTRE - GRAVELINES : revenue, balance sheet and financial ratios
PHARMACIE DU CENTRE - GRAVELINES is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GRAVELINES (59820),
this company of category PME
shows in 2017 a revenue of 1.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CENTRE - GRAVELINES (SIREN 798966263)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 048 973 €
Net income
-112 349 €
-88 275 €
131 303 €
30 100 €
61 726 €
77 621 €
75 980 €
70 835 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
94 164 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
6.8%
Revenue and income statement
In 2024, PHARMACIE DU CENTRE - GRAVELINES records a net loss of 112 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-112 349 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 948%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
948.368%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
8.676%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU CENTRE - GRAVELINES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
146.734
119.832
100.972
78.725
62.246
0.902
681.689
948.368
Financial autonomy
35.567
40.141
42.819
48.6
51.378
92.188
11.885
8.676
Repayment capacity
5.799
None
None
None
None
None
None
None
Cash flow / Revenue
7.646%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
948.372024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+50 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU CENTRE - GRA... (948.37) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
8.68%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch-54 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU CENTRE - GRA... (8.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 166.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
166.74
Liquidity indicators evolution PHARMACIE DU CENTRE - GRAVELINES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
226.558
263.482
226.346
220.907
181.967
1424.362
188.509
166.74
Interest coverage
8.273
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
166.742024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-32 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU CENTRE - GRA... (166.74) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU CENTRE - GRAVELINES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
126 338 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
24
0
0
0
0
0
0
0
Customer payment term (days)
6
0
0
0
0
0
0
0
Supplier payment term (days)
35
0
0
0
0
0
0
0
Positioning of PHARMACIE DU CENTRE - GRAVELINES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CENTRE - GRAVELINES with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CENTRE - GRAVELINES
What is the revenue of PHARMACIE DU CENTRE - GRAVELINES ?
The revenue of PHARMACIE DU CENTRE - GRAVELINES in 2017 is 1.0 M€.
Is PHARMACIE DU CENTRE - GRAVELINES profitable?
PHARMACIE DU CENTRE - GRAVELINES recorded a net loss in 2024.
Where is the headquarters of PHARMACIE DU CENTRE - GRAVELINES ?
The headquarters of PHARMACIE DU CENTRE - GRAVELINES is located in GRAVELINES (59820), in the department Nord.
Where to find the tax return of PHARMACIE DU CENTRE - GRAVELINES ?
The tax return of PHARMACIE DU CENTRE - GRAVELINES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CENTRE - GRAVELINES operate?
PHARMACIE DU CENTRE - GRAVELINES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart